HopeStage
Back to all studies
RecruitingNCT04216186

Study of coenzyme Q in children with ADHD

About this titleRead the official source — NCT04216186
Medication studyAges 2–18Egypt
The study in practice

Understand this study

Who could participate?

This study is for people with ADHD. Listed age limits: 2 years to 18 years. Other eligibility criteria apply.

Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 1, 2018
Recruitment status
Recruiting
Enrollment listed in the registry
40
Sponsor
Sherief Abd-Elsalam
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Egypt
Age range
From 2 Years to 18 Years
Official registry ID
NCT04216186
Official title
Show the full official title

Role of Coenzyme Q in Treatment of Attention Deficit Hyperactivity Disorder in Children

Recruitment & locations

Currently recruiting

Tanta

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Sherief Abd-Elsalam.

Does this study involve medication?

Yes. The study involves medication, including Atomoxetine and Coenzyme Q.

Who can participate?

This study is for people with ADHD. Listed age limits: 2 years to 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies